SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

HC Wainwright & Co. Reiterates Buy on Clovis Oncology, Lowers Price Target to $29

HC Wainwright & Co. reiterates Clovis Oncology (NASDAQ:CLVS) with a Buy and lowers the price target from $33 to $29.

Benzinga · 05/22/2020 10:55

HC Wainwright & Co. reiterates Clovis Oncology (NASDAQ:CLVS) with a Buy and lowers the price target from $33 to $29.